ABzOH

CAS No. 1313028-09-9

ABzOH( —— )

Catalog No. M36081 CAS No. 1313028-09-9

ABzOH is a benzoic acid derivative, similar in structure to non-steroidal anti-inflammatory drugs such as aspirin, with anti-inflammatory, anti-tumor and anti-proliferative effects.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 296 Get Quote
5MG 427 Get Quote
10MG 626 Get Quote
25MG 908 Get Quote
50MG 1279 Get Quote
100MG 1692 Get Quote
500MG 3402 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    ABzOH
  • Note
    Research use only, not for human use.
  • Brief Description
    ABzOH is a benzoic acid derivative, similar in structure to non-steroidal anti-inflammatory drugs such as aspirin, with anti-inflammatory, anti-tumor and anti-proliferative effects.
  • Description
    ABzOH is a benzoic acid derivative, similar in structure to non-steroidal anti-inflammatory drugs such as aspirin, with anti-inflammatory, anti-tumor and anti-proliferative effects. ABzOH can not only inhibit the expression of tumor necrosis factor-α (TNF-a), interleukin-1β (IL-1β), interleukin-6 (IL-6) and other pro-inflammatory cytokines, but also inhibit breast cancer, lung cancer and pancreatic cancer.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Apoptosis
  • Target
    IL Receptor
  • Recptor
    IL Receptor | TNF
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1313028-09-9
  • Formula Weight
    186.21
  • Molecular Formula
    C12H10O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(#CC1CC1)C2=C(C(O)=O)C=CC=C2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Secukinumab

    Secukinumab is a fully humanized monoclonal anti-IL-17A antibody and the first in its class to be approved by the US Food and Drug Administration for the treatment of moderate to severe plaque psoriasis.

  • Anakinra

    Anakinra (Raleukin) is a cytokine inactivator and interleukin 1 receptor antagonist that can be used to study secondary phagocytic lymphohistiocytosis and rheumatoid arthritis.

  • N-Methylnuciferine

    N-Methylnuciferine, an alkaloid from?Lotus Plumule, ameliorate lipopolysaccharide-induced depression-like behavior.